IQVIA HOLDINGS INC. Net Realized and Unrealized Gain (Loss) on Trading Securities
IQVIA HOLDINGS INC. (IQV) reported Net Realized and Unrealized Gain (Loss) on Trading Securities of $3.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-16.
Discontinued › Income Statement › Other Income
us-gaap:NetRealizedOrUnrealizedGainLossOnTradingSecurities · last filed 2017-02-16
- IQVIA HOLDINGS INC. net realized and unrealized gain (loss) on trading securities for the quarter ending 2016-12-31 was $600.00K.
- IQVIA HOLDINGS INC. net realized and unrealized gain (loss) on trading securities for the quarter ending 2016-09-30 was $1.70M.
- IQVIA HOLDINGS INC. net realized and unrealized gain (loss) on trading securities for the quarter ending 2016-06-30 was $499.00K.
- IQVIA HOLDINGS INC. net realized and unrealized gain (loss) on trading securities for the quarter ending 2016-03-31 was $230.00K.
- IQVIA HOLDINGS INC. net realized and unrealized gain (loss) on trading securities for fiscal 2016 was $3.00M.
| Period end | Net Realized and Unrealized Gain (Loss) on Trading Securities 3 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 6 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 9 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.30M derived: sum of 2 quarters · filed 2017-02-16 | $2.80M derived: sum of 3 quarters · filed 2017-02-16 | $3.00M 10-K · filed 2017-02-16 |
| 2016-09-30 | $1.70M 10-Q · filed 2016-11-03 | $2.20M derived: sum of 2 quarters · filed 2016-11-03 | $2.40M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $499.00K 10-Q · filed 2016-07-27 | $729.00K 10-Q · filed 2016-07-27 | ||
| 2016-03-31 | $230.00K 10-Q · filed 2016-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |